SNPHY Projected Dividend Yield
ADR/Santen Pharmaceutical Co., Ltd. ( OTCBB : SNPHY )Santen Pharmaceutical is a pharmaceutical company mainly engaged in the research and development, production and marketing of pharmaceuticals and medical devices. Co. operates its business in Japan, Asia, North America, Europe, Middle East and Africa, and sells its products in over 50 countries. Co. offers prescription ophthalmic pharmaceutical products such as treatments for corneal and conjunctival epithelial disorders, glaucoma, anti-infective ophthalmics and anti-allergy ophthalmics. Co. also officers over-the-counter (OTC) pharmaceuticals such as eye drops. In addition, Co. provides ophthalmic medical devices used in cataract surgery, and cleaning services for sterilized clothes. 23 YEAR PERFORMANCE RESULTS |
SNPHY Dividend History Detail SNPHY Dividend News SNPHY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
N/A |
Sep 30, 2024 |
Dec 16, 2024 |
0.1131 |
2024 |
N/A |
N/A |
Mar 28, 2024 |
Jul 11, 2024 |
0.1057 |
2024 Total: |
0.2188 |
||||
2023 |
N/A |
N/A |
Sep 29, 2023 |
Dec 15, 2023 |
0.1076 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jul 13, 2023 |
0.1106 |
2023 Total: |
0.2182 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 15, 2022 |
0.1149 |
2022 |
N/A |
N/A |
Mar 30, 2022 |
Jul 12, 2022 |
0.1181 |
2022 Total: |
0.2330 |
||||
2021 |
N/A |
N/A |
Sep 29, 2021 |
Dec 15, 2021 |
0.1414 |
2021 |
N/A |
N/A |
Mar 30, 2021 |
Jul 13, 2021 |
0.1262 |
2021 Total: |
0.2676 |
||||
2020 |
N/A |
N/A |
Sep 29, 2020 |
Dec 15, 2020 |
0.1343 |
2020 |
N/A |
N/A |
Mar 30, 2020 |
Jul 10, 2020 |
0.1304 |
2020 Total: |
0.2646 |
||||
2019 |
N/A |
N/A |
Sep 27, 2019 |
Dec 16, 2019 |
0.1186 |
2019 |
N/A |
N/A |
Mar 29, 2019 |
Jul 11, 2019 |
0.1206 |
2019 Total: |
0.2391 |